All lobbying filings

Brownstein Hyatt Farber Schreck, LLP

Brownstein Hyatt Farber Schreck, LLP filed a Q3 report for Novartis on October 19, 2026, reporting $90,000 in lobbying income.

Lobbying for Novartis · Multinational biopharmaceutical company

As filed: BROWNSTEIN HYATT FARBER SCHRECK, LLP for NOVARTIS.

All filings by Brownstein Hyatt Farber Schreck, LLP · Everything Novartis has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Income

$90,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 2

SARA MORSE New on this filing

Previously held: Principal Deputy Assistant Secretary for Legislation at the Department of Health and Human Services; Deputy Assistant Secretary for Legislation at the Department of Health and Human Services
LAUREN ALEXANDRA MISH New on this filing

Previously held: "Intern, Rep. Brian Fitzpatrick (PA-01); Intern, Department of Health and Human Services in the Office of Global Affairs

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to cell and gene therapy and radioligand therapies Pharmaceutical pricing Issues related to the development of therapies for rare diseases 340B Drug Discount Program Supply chain issues affecting pharmaceutical products Implementation of the Inflation reduction Act Pharmaceutical innovation PBM policy issues HR 1672 The Maintaining Investments in New Innovations (MINI) Act Intellectual property Issues Tariff issues affecting the pharmaceutical industry EPIC Act Most Favored Nation (MFN) policy Tribal health issues

Bills named in this filing 1

H.R. 1672
Maintaining Investments in New Innovation Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.